Literature DB >> 33531559

Cannabis sativa L. may reduce aggressive behaviour towards humans in shelter dogs.

Sara Corsetti1, Simona Borruso2, Livia Malandrucco3, Valentina Spallucci4, Laura Maragliano3, Raffaella Perino3, Pietro D'Agostino5, Eugenia Natoli3.   

Abstract

Among the phytocomplex components of Cannabis sativa L., cannabidiol (CBD) has a recognised therapeutic effect on chronic pain. Little is known about the veterinary use of CBD in dogs. Even less is known on the effects of CBD on dog behaviour, especially in shelters. The purpose of this study was to determine if CBD affects stress related behaviour in shelter dogs. The sample consisted of 24 dogs divided into two groups that were created by assigning the dogs alternately: 12 dogs were assigned to the treatment group and 12 to the control group. Extra virgin olive oil, titrated to 5% in CBD was given to treated group; the placebo consisted of olive oil only, dispensed daily for 45 days. Behavioural data were collected using the 'focal animal' sampling method with 'all occurrences' and '1/0' methods for 3 h: before (T0), after 15 days (T1), after 45 days of treatment (T2) and after 15 days from the end of the treatment (T3). Treated dogs showed reduced aggressive behaviour toward humans following the treatment (Friedman Test: χ2 = 13.300; df = 3; N = 12; p = .004; adj. sig. p = 0.027), but the difference in the decrease of aggressive behaviour between the two groups was not significant (Mann-Whitney U test, T2-T0: Z = - 1.81; N = 24; p = 0.078). Other behaviours indicative of stress, such as displacing activities and stereotypes, did not decrease. Despite some non-significant results, our findings suggest that it is worth doing more research to further investigate the effect of CBD on dog behaviour; this would be certainly valuable because the potential for improving the welfare of dogs in shelters is priceless.

Entities:  

Year:  2021        PMID: 33531559     DOI: 10.1038/s41598-021-82439-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  37 in total

1.  Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study.

Authors:  Hendrika H van Hell; Matthijs G Bossong; Gerry Jager; Gert Kristo; Matthias J P van Osch; Fernando Zelaya; René S Kahn; Nick F Ramsey
Journal:  Int J Neuropsychopharmacol       Date:  2011-04-14       Impact factor: 5.176

Review 2.  Phytocannabinoids as novel therapeutic agents in CNS disorders.

Authors:  Andrew J Hill; Claire M Williams; Benjamin J Whalley; Gary J Stephens
Journal:  Pharmacol Ther       Date:  2011-09-06       Impact factor: 12.310

3.  Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.

Authors:  Lisa R Bartner; Stephanie McGrath; Sangeeta Rao; Linda K Hyatt; Luke A Wittenburg
Journal:  Can J Vet Res       Date:  2018-07       Impact factor: 1.310

4.  Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents - An observational, longitudinal study.

Authors:  Moran Hausman-Kedem; Shay Menascu; Uri Kramer
Journal:  Brain Dev       Date:  2018-04-16       Impact factor: 1.961

Review 5.  Chemical constituents of marijuana: the complex mixture of natural cannabinoids.

Authors:  Mahmoud A Elsohly; Desmond Slade
Journal:  Life Sci       Date:  2005-09-30       Impact factor: 5.037

6.  Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation.

Authors:  Saphala Dhital; John V Stokes; Nogi Park; Keun Seok Seo; Barbara L F Kaplan
Journal:  Cell Immunol       Date:  2016-11-09       Impact factor: 4.868

7.  Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.

Authors:  Francisco Espejo-Porras; Javier Fernández-Ruiz; Roger G Pertwee; Raphael Mechoulam; Concepción García
Journal:  Neuropharmacology       Date:  2013-08-04       Impact factor: 5.250

Review 8.  Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Drug Metab Rev       Date:  2016-02-01       Impact factor: 4.518

9.  Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.

Authors:  Sagnik Bhattacharyya; Paolo Fusar-Poli; Stefan Borgwardt; Rocio Martin-Santos; Chiara Nosarti; Colin O'Carroll; Paul Allen; Marc L Seal; Paul C Fletcher; José A Crippa; Vincent Giampietro; Andrea Mechelli; Zerrin Atakan; Philip McGuire
Journal:  Arch Gen Psychiatry       Date:  2009-04

10.  Marijuana intoxication in a cat.

Authors:  Agnieszka Janeczek; Marcin Zawadzki; Pawel Szpot; Artur Niedzwiedz
Journal:  Acta Vet Scand       Date:  2018-07-11       Impact factor: 1.695

View more
  1 in total

1.  Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs.

Authors:  Dakir Polidoro; Robin Temmerman; Mathias Devreese; Marios Charalambous; Luc Van Ham; Ine Cornelis; Bart J G Broeckx; Paul J J Mandigers; Andrea Fischer; Jan Storch; Sofie F M Bhatti
Journal:  Front Vet Sci       Date:  2022-06-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.